Transcriptomics

Dataset Information

0

Central Inhibition of HDAC6 Re-Sensitizes Leptin Signaling During Obesity to Induce Profound Weight Loss


ABSTRACT: Leptin resistance during excess weigh gain significantly contributes to the recidivism of obesity to leptin-based pharmacological therapies. The mechanisms underlying the inhibition of Leptin receptor b (LepR) signaling during obesity is still elusive. Here we report that histone deactylase 6 (HDAC6) interacts with LepR, reducing the latter’s activity, and that pharmacological inhibition of HDAC6 activity disrupts this interaction and augments leptin signaling. Treatment of obese mice with blood brain barrier (BBB)-permeable HDAC6 inhibitors profoundly reduces food intake and leads to a potent weight loss without affecting the muscle mass. Genetic depletion of Hdac6 in AgRP-expressing neurons or administration with BBB-impermeable HDAC6 inhibitors result in a lack of such anti-obesity effect. Together, these findings represent the first report describing a mechanistically validated and pharmaceutically tractable therapeutic approach to directly increase LepR activity as well as identifying centrally-, but not peripherally-acting HDAC6 inhibitors as potent leptin-sensitizers and anti-obesity agents.

ORGANISM(S): Mus musculus

PROVIDER: GSE252779 | GEO | 2024/01/09

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2021-09-09 | PXD020959 | Pride
2024-07-03 | PXD043087 | Pride
2021-12-05 | GSE190156 | GEO
2023-12-12 | GSE227493 | GEO
2008-10-25 | E-GEOD-12209 | biostudies-arrayexpress
2008-09-04 | GSE12209 | GEO
2023-10-02 | GSE243984 | GEO
2023-06-14 | GSE211757 | GEO
2014-08-05 | E-GEOD-60053 | biostudies-arrayexpress
2017-03-31 | GSE97243 | GEO